Business
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board
Newly Appointed Members Include Leaders in Vaccine Immunology, T-Cell Science, and Clinical Research ATLANTA, GA - December 10, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen va...
About this update from Geovax Labs, Inc.
[{"type":"image","caption":"","headline":"GeoVax Highlights 2026 as a Pivotal Year for Progress","size":{"original":{"width":140,"height":140,"url":"https://media.zenfs.com/en/newsmediawire_165/6b870301b9c37c9b2d12fc8f9b2a2ecc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CK3y_RQaAtNDQGf8lPQXOQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/6b870301b9c37c9b2d12fc8f9b2a2ecc","width":140,"height":140}}},{"type":"text","content":"Newly Appointed Members Include Leaders in Vaccine Immunology, T-Cell Science, and Clinical Research","length":100,"tagName":"p"},{"type":"text","content":"ATLANTA, GA - December 10, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancers, today announced an update to its Scientific Advisory Board (SAB), welcoming internationally recognized experts whose work spans vaccine design, T-cell immunology, viral pathogenesis, and immunocompromised-host medicine.","length":432,"tagName":"p"},{"type":"text","content":"This strategic expansion is designed to support GeoVax's current and future development efforts with MVA and its multi-antigen MVA vector platform for vaccines targeting biothreat pathogens and vulnerable or currently underserved populations such as those from low- and middle-income countries, and immunocompromised patients. Future additions to the GeoVax SAB will support its oncology immunotherapy pipeline.","length":415,"tagName":"p"},{"type":"text","content":"Newly Announced SAB Members","length":27,"tagName":"p"},{"type":"text","content":"Joining Prof. Teresa Lambe, PhD, OBE, FMedSci - Calleva Head of Vaccine Immunology, Oxford Vaccine Group / Jenner Institute, University of Oxford, whose appointment to the GeoVax SAB was previously announced, are the following:","length":227,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Dr. Alessandro Sette, Dr of Biological Sciences - Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology","length":135,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":135,"olType":false},{"type":"text","content":"An authority in T-cell epitope mapping and immune correlates of protection, Dr. Sette leads the NIH Immune Epitope Database (IEDB) and is w...